Jason Dyck - Publications

2011 Neuroscience University of Alberta, Edmonton, Alberta, Canada 

111 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Groenendyk J, Lee D, Jung J, Dyck JR, Lopaschuk GD, Agellon LB, Michalak M. Inhibition of the Unfolded Protein Response Mechanism Prevents Cardiac Fibrosis. Plos One. 11: e0159682. PMID 27441395 DOI: 10.1371/journal.pone.0159682  1
2016 Ussher JR, Fillmore N, Keung W, Zhang L, Mori J, Sidhu VK, Fukushima A, Gopal K, Lopaschuk DG, Wagg CS, Jaswal JS, Dyck JR, Lopaschuk GD. Genetic and pharmacological inhibition of malonyl CoA decarboxylase does not exacerbate age-related insulin resistance in mice. Diabetes. PMID 27207536 DOI: 10.2337/db15-1145  1
2016 Kim TT, Dyck JR. The role of CD36 in the regulation of myocardial lipid metabolism. Biochimica Et Biophysica Acta. PMID 26995462 DOI: 10.1016/j.bbalip.2016.03.018  1
2016 Byrne NJ, Levasseur J, Sung MM, Masson G, Boisvenue J, Young ME, Dyck JR. Normalization of Cardiac Substrate Utilization and Left Ventricular Hypertrophy Precede Functional Recovery in Heart Failure Regression. Cardiovascular Research. PMID 26968698 DOI: 10.1093/cvr/cvw051  1
2015 Das SK, Wang W, Zhabyeyev P, Basu R, McLean B, Fan D, Parajuli N, DesAulniers J, Patel VB, Hajjar RJ, Dyck JR, Kassiri Z, Oudit GY. Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy. Scientific Reports. 5: 18132. PMID 26638758 DOI: 10.1038/srep18132  1
2015 Britz O, Zhang J, Grossmann KS, Dyck J, Kim JC, Dymecki S, Gosgnach S, Goulding M. Correction: A genetically defined asymmetry underlies the inhibitory control of flexor-extensor locomotor movements. Elife. 4. PMID 26606138 DOI: 10.7554/eLife.13038  1
2015 Britz O, Zhang J, Grossmann KS, Dyck J, Kim JC, Dymecki S, Gosgnach S, Goulding M. A genetically defined asymmetry underlies the inhibitory control of flexor-extensor locomotor movements. Elife. 4. PMID 26465208 DOI: 10.7554/eLife.04718  1
2015 Fritzen AM, Lundsgaard AM, Jeppesen J, Christiansen ML, Biensø R, Dyck JR, Pilegaard H, Kiens B. 5´AMP activated protein kinase α2 controls substrate metabolism during post-exercise recovery via regulation of pyruvate dehydrogenase kinase 4. The Journal of Physiology. PMID 26359931 DOI: 10.1113/JP270821  1
2015 Law J, Salla M, Zare A, Wong Y, Luong L, Volodko N, Svystun O, Flood K, Lim J, Sung M, Dyck JR, Tan CT, Su YC, Yu VC, Mackey J, et al. Modulator of Apoptosis 1 (MOAP-1) is a tumor suppressor protein linked to RASSF1A. The Journal of Biological Chemistry. PMID 26269600 DOI: 10.1074/jbc.M115.648345  1
2015 Das SK, DesAulniers J, Dyck JR, Kassiri Z, Oudit GY. Resveratrol mediates therapeutic hepatic effects in acquired and genetic murine models of iron-overload. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 26077449 DOI: 10.1111/liv.12893  1
2015 Sung MM, Zordoky BN, Bujak AL, Lally JS, Fung D, Young ME, Horman S, Miller EJ, Light PE, Kemp BE, Steinberg GR, Dyck JR. AMPK deficiency in cardiac muscle results in dilated cardiomyopathy in the absence of changes in energy metabolism. Cardiovascular Research. 107: 235-45. PMID 26023060 DOI: 10.1093/cvr/cvv166  1
2015 Zordoky BN, Sung MM, Ezekowitz J, Mandal R, Han B, Bjorndahl TC, Bouatra S, Anderson T, Oudit GY, Wishart DS, Dyck JR. Metabolomic fingerprint of heart failure with preserved ejection fraction. Plos One. 10: e0124844. PMID 26010610 DOI: 10.1371/journal.pone.0124844  1
2015 Sung MM, Hamza SM, Dyck JR. Myocardial metabolism in diabetic cardiomyopathy: potential therapeutic targets. Antioxidants & Redox Signaling. 22: 1606-30. PMID 25808033 DOI: 10.1089/ars.2015.6305  1
2015 Dyck JR, Schrauwen P. Resveratrol: Challenges in translating pre-clinical findings to improved patient outcomes. Biochimica Et Biophysica Acta. 1852: 1069-70. PMID 25700724 DOI: 10.1016/j.bbadis.2015.02.002  1
2015 Edgell H, McMurtry MS, Haykowsky MJ, Paterson I, Ezekowitz JA, Dyck JR, Stickland MK. Peripheral chemoreceptor control of cardiovascular function at rest and during exercise in heart failure patients. Journal of Applied Physiology (Bethesda, Md. : 1985). 118: 839-48. PMID 25614600 DOI: 10.1152/japplphysiol.00898.2014  1
2015 Crane JD, Palanivel R, Mottillo EP, Bujak AL, Wang H, Ford RJ, Collins A, Blümer RM, Fullerton MD, Yabut JM, Kim JJ, Ghia JE, Hamza SM, Morrison KM, Schertzer JD, ... Dyck JR, et al. Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis. Nature Medicine. 21: 166-72. PMID 25485911 DOI: 10.1038/nm.3766  1
2015 Zordoky BN, Robertson IM, Dyck JR. Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases. Biochimica Et Biophysica Acta. 1852: 1155-1177. PMID 25451966 DOI: 10.1016/j.bbadis.2014.10.016  1
2015 Kim TT, Dyck JR. Is AMPK the savior of the failing heart? Trends in Endocrinology and Metabolism: Tem. 26: 40-8. PMID 25439672 DOI: 10.1016/j.tem.2014.11.001  1
2015 Gao X, van der Veen JN, Zhu L, Chaba T, Ordoñez M, Lingrell S, Koonen DP, Dyck JR, Gomez-Muñoz A, Vance DE, Jacobs RL. Vagus nerve contributes to the development of steatohepatitis and obesity in phosphatidylethanolamine N-methyltransferase deficient mice. Journal of Hepatology. 62: 913-20. PMID 25433161 DOI: 10.1016/j.jhep.2014.11.026  1
2015 Dolinsky VW, Soltys CL, Rogan KJ, Chan AY, Nagendran J, Wang S, Dyck JR. Resveratrol prevents pathological but not physiological cardiac hypertrophy. Journal of Molecular Medicine (Berlin, Germany). 93: 413-25. PMID 25394677 DOI: 10.1007/s00109-014-1220-8  1
2015 Sung MM, Das SK, Levasseur J, Byrne NJ, Fung D, Kim TT, Masson G, Boisvenue J, Soltys CL, Oudit GY, Dyck JR. Resveratrol treatment of mice with pressure-overload-induced heart failure improves diastolic function and cardiac energy metabolism. Circulation. Heart Failure. 8: 128-37. PMID 25394648 DOI: 10.1161/CIRCHEARTFAILURE.114.001677  1
2015 Sung MM, Dyck JRB. Therapeutic potential of resveratrol in heart failure Annals of the New York Academy of Sciences. DOI: 10.1111/nyas.12839  1
2015 Poppe KK, Doughty RN, Gardin JM, Hobbs FDR, McMurray JJV, Nagueh SF, Senior R, Thomas L, Whalley GA, Aune E, Brown A, Badano LP, Cameron V, Chadha DS, Chahal N, ... ... Dyck J, et al. Ethnic-specific normative reference values for echocardiographic la and LV size, LV mass, and systolic function: The EchoNoRMAL study Jacc: Cardiovascular Imaging. 8: 656-665. DOI: 10.1016/j.jcmg.2015.02.014  1
2014 Dolinsky VW, Dyck JR. Experimental studies of the molecular pathways regulated by exercise and resveratrol in heart, skeletal muscle and the vasculature. Molecules (Basel, Switzerland). 19: 14919-47. PMID 25237749 DOI: 10.3390/molecules190914919  1
2014 Hamza SM, Dyck JR. Systemic and renal oxidative stress in the pathogenesis of hypertension: modulation of long-term control of arterial blood pressure by resveratrol. Frontiers in Physiology. 5: 292. PMID 25140155 DOI: 10.3389/fphys.2014.00292  1
2014 Ezekowitz JA, Becher H, Belenkie I, Clark AM, Duff HJ, Friedrich MG, Haykowsky MJ, Howlett JG, Kassiri Z, Kaul P, Kim DH, Knudtson ML, Light PE, Lopaschuk GD, McAlister FA, ... ... Dyck JR, et al. The Alberta Heart Failure Etiology and Analysis Research Team (HEART) study. Bmc Cardiovascular Disorders. 14: 91. PMID 25063541 DOI: 10.1186/1471-2261-14-91  1
2014 Zordoky BN, Nagendran J, Pulinilkunnil T, Kienesberger PC, Masson G, Waller TJ, Kemp BE, Steinberg GR, Dyck JR. AMPK-dependent inhibitory phosphorylation of ACC is not essential for maintaining myocardial fatty acid oxidation. Circulation Research. 115: 518-24. PMID 25001074 DOI: 10.1161/CIRCRESAHA.115.304538  1
2014 Putko BN, Wang Z, Lo J, Anderson T, Becher H, Dyck JR, Kassiri Z, Oudit GY. Circulating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiology. Plos One. 9: e99495. PMID 24923671 DOI: 10.1371/journal.pone.0099495  1
2014 O'Neill HM, Lally JS, Galic S, Thomas M, Azizi PD, Fullerton MD, Smith BK, Pulinilkunnil T, Chen Z, Samaan MC, Jorgensen SB, Dyck JR, Holloway GP, Hawke TJ, van Denderen BJ, et al. AMPK phosphorylation of ACC2 is required for skeletal muscle fatty acid oxidation and insulin sensitivity in mice. Diabetologia. 57: 1693-702. PMID 24913514 DOI: 10.1007/s00125-014-3273-1  1
2014 Clark AM, Narine KA, Hsu ZY, Wiens KS, Anderson TJ, Dyck JR. Preparing today's cardiovascular trainees to meet the challenges of tomorrow: team research and interdisciplinary training. The Canadian Journal of Cardiology. 30: 683-6. PMID 24882543 DOI: 10.1016/j.cjca.2014.02.019  1
2014 Yu Y, Carter CR, Youssef N, Dyck JR, Light PE. Intracellular long-chain acyl CoAs activate TRPV1 channels. Plos One. 9: e96597. PMID 24798548 DOI: 10.1371/journal.pone.0096597  1
2014 Sheedfar F, Sung MM, Aparicio-Vergara M, Kloosterhuis NJ, Miquilena-Colina ME, Vargas-Castrillón J, Febbraio M, Jacobs RL, de Bruin A, Vinciguerra M, García-Monzón C, Hofker MH, Dyck JR, Koonen DP. Increased hepatic CD36 expression with age is associated with enhanced susceptibility to nonalcoholic fatty liver disease. Aging. 6: 281-95. PMID 24751397  1
2014 Hollander Z, Lazárová M, Lam KK, Ignaszewski A, Oudit GY, Dyck JR, Schreiner G, Pauwels J, Chen V, Cohen Freue GV, Ng RT, Wilson-McManus JE, Balshaw R, Tebbutt SJ, McMaster RW, et al. Proteomic biomarkers of recovered heart function. European Journal of Heart Failure. 16: 551-9. PMID 24574204 DOI: 10.1002/ejhf.65  1
2014 Zordoky BN, Bark D, Soltys CL, Sung MM, Dyck JR. The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention. Biochimica Et Biophysica Acta. 1840: 1943-57. PMID 24462945 DOI: 10.1016/j.bbagen.2014.01.023  1
2014 Baczko I, Liknes D, Yang W, Hamming KC, Searle G, Jaeger K, Husti Z, Juhasz V, Klausz G, Pap R, Saghy L, Varro A, Dolinsky V, Wang S, Rauniyar V, ... ... Dyck JR, et al. Characterization of a novel multifunctional resveratrol derivative for the treatment of atrial fibrillation. British Journal of Pharmacology. 171: 92-106. PMID 24102184 DOI: 10.1111/bph.12409  1
2014 Masoud WG, Ussher JR, Wang W, Jaswal JS, Wagg CS, Dyck JR, Lygate CA, Neubauer S, Clanachan AS, Lopaschuk GD. Failing mouse hearts utilize energy inefficiently and benefit from improved coupling of glycolysis and glucose oxidation. Cardiovascular Research. 101: 30-8. PMID 24048945 DOI: 10.1093/cvr/cvt216  1
2014 Pulinilkunnil T, Kienesberger PC, Nagendran J, Sharma N, Young ME, Dyck JR. Cardiac-specific adipose triglyceride lipase overexpression protects from cardiac steatosis and dilated cardiomyopathy following diet-induced obesity. International Journal of Obesity (2005). 38: 205-15. PMID 23817015 DOI: 10.1038/ijo.2013.103  1
2013 Fullerton MD, Galic S, Marcinko K, Sikkema S, Pulinilkunnil T, Chen ZP, O'Neill HM, Ford RJ, Palanivel R, O'Brien M, Hardie DG, Macaulay SL, Schertzer JD, Dyck JR, van Denderen BJ, et al. Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin. Nature Medicine. 19: 1649-54. PMID 24185692 DOI: 10.1038/nm.3372  1
2013 Breckenridge RA, Piotrowska I, Ng KE, Ragan TJ, West JA, Kotecha S, Towers N, Bennett M, Kienesberger PC, Smolenski RT, Siddall HK, Offer JL, Mocanu MM, Yelon DM, Dyck JR, et al. Hypoxic regulation of hand1 controls the fetal-neonatal switch in cardiac metabolism. Plos Biology. 11: e1001666. PMID 24086110 DOI: 10.1371/journal.pbio.1001666  1
2013 Nagendran J, Pulinilkunnil T, Kienesberger PC, Sung MM, Fung D, Febbraio M, Dyck JR. Cardiomyocyte-specific ablation of CD36 improves post-ischemic functional recovery. Journal of Molecular and Cellular Cardiology. 63: 180-8. PMID 23948483 DOI: 10.1016/j.yjmcc.2013.07.020  1
2013 Griener A, Dyck J, Gosgnach S. Regional distribution of putative rhythm-generating and pattern-forming components of the mammalian locomotor CPG. Neuroscience. 250: 644-50. PMID 23933310 DOI: 10.1016/j.neuroscience.2013.07.070  1
2013 Pung YF, Sam WJ, Stevanov K, Enrick M, Chen CL, Kolz C, Thakker P, Hardwick JP, Chen YR, Dyck JR, Yin L, Chilian WM. Mitochondrial oxidative stress corrupts coronary collateral growth by activating adenosine monophosphate activated kinase-α signaling. Arteriosclerosis, Thrombosis, and Vascular Biology. 33: 1911-9. PMID 23788766 DOI: 10.1161/ATVBAHA.113.301591  1
2013 Kienesberger PC, Pulinilkunnil T, Nagendran J, Young ME, Bogner-Strauss JG, Hackl H, Khadour R, Heydari E, Haemmerle G, Zechner R, Kershaw EE, Dyck JR. Early structural and metabolic cardiac remodelling in response to inducible adipose triglyceride lipase ablation. Cardiovascular Research. 99: 442-51. PMID 23708736 DOI: 10.1093/cvr/cvt124  1
2013 Dolinsky VW, Chakrabarti S, Pereira TJ, Oka T, Levasseur J, Beker D, Zordoky BN, Morton JS, Nagendran J, Lopaschuk GD, Davidge ST, Dyck JR. Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice. Biochimica Et Biophysica Acta. 1832: 1723-33. PMID 23707558 DOI: 10.1016/j.bbadis.2013.05.018  1
2013 Nagendran J, Kienesberger PC, Pulinilkunnil T, Zordoky BN, Sung MM, Kim T, Young ME, Dyck JR. Cardiomyocyte specific adipose triglyceride lipase overexpression prevents doxorubicin induced cardiac dysfunction in female mice. Heart (British Cardiac Society). 99: 1041-7. PMID 23704323 DOI: 10.1136/heartjnl-2013-303843  1
2013 Dolinsky VW, Rogan KJ, Sung MM, Zordoky BN, Haykowsky MJ, Young ME, Jones LW, Dyck JR. Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice. American Journal of Physiology. Endocrinology and Metabolism. 305: E243-53. PMID 23695218 DOI: 10.1152/ajpendo.00044.2013  1
2013 Nagendran J, Oudit GY, Bakal JA, Light PE, Dyck JR, McAlister FA. Are users of sulphonylureas at the time of an acute coronary syndrome at risk of poorer outcomes? Diabetes, Obesity & Metabolism. 15: 1022-8. PMID 23668425 DOI: 10.1111/dom.12126  1
2013 Kok BP, Dyck JR, Harris TE, Brindley DN. Differential regulation of the expressions of the PGC-1α splice variants, lipins, and PPARα in heart compared to liver. Journal of Lipid Research. 54: 1662-77. PMID 23505321 DOI: 10.1194/jlr.M036624  1
2013 Lee D, Oka T, Hunter B, Robinson A, Papp S, Nakamura K, Srisakuldee W, Nickel BE, Light PE, Dyck JR, Lopaschuk GD, Kardami E, Opas M, Michalak M. Calreticulin induces dilated cardiomyopathy. Plos One. 8: e56387. PMID 23437120 DOI: 10.1371/journal.pone.0056387  1
2013 Jeppesen J, Maarbjerg SJ, Jordy AB, Fritzen AM, Pehmøller C, Sylow L, Serup AK, Jessen N, Thorsen K, Prats C, Qvortrup K, Dyck JR, Hunter RW, Sakamoto K, Thomson DM, et al. LKB1 regulates lipid oxidation during exercise independently of AMPK. Diabetes. 62: 1490-9. PMID 23349504 DOI: 10.2337/db12-1160  1
2013 Pulinilkunnil T, Kienesberger PC, Nagendran J, Waller TJ, Young ME, Kershaw EE, Korbutt G, Haemmerle G, Zechner R, Dyck JR. Myocardial adipose triglyceride lipase overexpression protects diabetic mice from the development of lipotoxic cardiomyopathy. Diabetes. 62: 1464-77. PMID 23349479 DOI: 10.2337/db12-0927  1
2013 Schroeder MA, Lau AZ, Chen AP, Gu Y, Nagendran J, Barry J, Hu X, Dyck JR, Tyler DJ, Clarke K, Connelly KA, Wright GA, Cunningham CH. Hyperpolarized (13)C magnetic resonance reveals early- and late-onset changes to in vivo pyruvate metabolism in the failing heart. European Journal of Heart Failure. 15: 130-40. PMID 23258802 DOI: 10.1093/eurjhf/hfs192  1
2013 Lauzier B, Vaillant F, Merlen C, Gélinas R, Bouchard B, Rivard ME, Labarthe F, Dolinsky VW, Dyck JR, Allen BG, Chatham JC, Des Rosiers C. Metabolic effects of glutamine on the heart: anaplerosis versus the hexosamine biosynthetic pathway. Journal of Molecular and Cellular Cardiology. 55: 92-100. PMID 23201305 DOI: 10.1016/j.yjmcc.2012.11.008  1
2013 McLean BA, Kienesberger PC, Wang W, Masson G, Zhabyeyev P, Dyck JR, Oudit GY. Enhanced recovery from ischemia-reperfusion injury in PI3Kα dominant negative hearts: investigating the role of alternate PI3K isoforms, increased glucose oxidation and MAPK signaling. Journal of Molecular and Cellular Cardiology. 54: 9-18. PMID 23142539 DOI: 10.1016/j.yjmcc.2012.10.015  1
2013 Carley AN, Bi J, Wang X, Banke NH, Dyck JR, O'Donnell JM, Lewandowski ED. Multiphasic triacylglycerol dynamics in the intact heart during acute in vivo overexpression of CD36. Journal of Lipid Research. 54: 97-106. PMID 23099442 DOI: 10.1194/jlr.M029991  1
2013 Kienesberger PC, Pulinilkunnil T, Nagendran J, Dyck JR. Myocardial triacylglycerol metabolism. Journal of Molecular and Cellular Cardiology. 55: 101-10. PMID 22789525 DOI: 10.1016/j.yjmcc.2012.06.018  1
2013 Nagendran J, Waller TJ, Dyck JR. AMPK signalling and the control of substrate use in the heart. Molecular and Cellular Endocrinology. 366: 180-93. PMID 22750050 DOI: 10.1016/j.mce.2012.06.015  1
2012 Kandasamy AD, Sung MM, Boisvenue JJ, Barr AJ, Dyck JR. Adiponectin gene therapy ameliorates high-fat, high-sucrose diet-induced metabolic perturbations in mice. Nutrition & Diabetes. 2: e45. PMID 23446660 DOI: 10.1038/nutd.2012.18  1
2012 Brown BF, Quon A, Dyck JR, Casey JR. Carbonic anhydrase II promotes cardiomyocyte hypertrophy. Canadian Journal of Physiology and Pharmacology. 90: 1599-610. PMID 23210439 DOI: 10.1139/y2012-142  1
2012 Chung JH, Manganiello V, Dyck JR. Resveratrol as a calorie restriction mimetic: therapeutic implications. Trends in Cell Biology. 22: 546-54. PMID 22885100 DOI: 10.1016/j.tcb.2012.07.004  1
2012 Rueda-Clausen CF, Morton JS, Dolinsky VW, Dyck JR, Davidge ST. Synergistic effects of prenatal hypoxia and postnatal high-fat diet in the development of cardiovascular pathology in young rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 303: R418-26. PMID 22739349 DOI: 10.1152/ajpregu.00148.2012  1
2012 Jones LW, Antonelli J, Masko EM, Broadwater G, Lascola CD, Fels D, Dewhirst MW, Dyck JR, Nagendran J, Flores CT, Betof AS, Nelson ER, Pollak M, Dash RC, Young ME, et al. Exercise modulation of the host-tumor interaction in an orthotopic model of murine prostate cancer. Journal of Applied Physiology (Bethesda, Md. : 1985). 113: 263-72. PMID 22604887 DOI: 10.1152/japplphysiol.01575.2011  1
2012 Breen DM, Dolinsky VW, Zhang H, Ghanim H, Guo J, Mroziewicz M, Tsiani EL, Bendeck MP, Dandona P, Dyck JR, Heximer SP, Giacca A. Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanism. Atherosclerosis. 222: 375-81. PMID 22552115 DOI: 10.1016/j.atherosclerosis.2012.03.021  1
2012 Dolinsky VW, Jones KE, Sidhu RS, Haykowsky M, Czubryt MP, Gordon T, Dyck JR. Improvements in skeletal muscle strength and cardiac function induced by resveratrol during exercise training contribute to enhanced exercise performance in rats. The Journal of Physiology. 590: 2783-99. PMID 22473781 DOI: 10.1113/jphysiol.2012.230490  1
2012 Dyck J, Lanuza GM, Gosgnach S. Functional characterization of dI6 interneurons in the neonatal mouse spinal cord. Journal of Neurophysiology. 107: 3256-66. PMID 22442567 DOI: 10.1152/jn.01132.2011  1
2012 Ussher JR, Wang W, Gandhi M, Keung W, Samokhvalov V, Oka T, Wagg CS, Jaswal JS, Harris RA, Clanachan AS, Dyck JR, Lopaschuk GD. Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury. Cardiovascular Research. 94: 359-69. PMID 22436846 DOI: 10.1093/cvr/cvs129  1
2012 Bourque SL, Dolinsky VW, Dyck JR, Davidge ST. Maternal resveratrol treatment during pregnancy improves adverse fetal outcomes in a rat model of severe hypoxia. Placenta. 33: 449-52. PMID 22321195 DOI: 10.1016/j.placenta.2012.01.012  1
2012 Kienesberger PC, Pulinilkunnil T, Sung MM, Nagendran J, Haemmerle G, Kershaw EE, Young ME, Light PE, Oudit GY, Zechner R, Dyck JR. Myocardial ATGL overexpression decreases the reliance on fatty acid oxidation and protects against pressure overload-induced cardiac dysfunction. Molecular and Cellular Biology. 32: 740-50. PMID 22158969 DOI: 10.1128/MCB.06470-11  1
2012 Sung MM, Dyck JR. Age-related cardiovascular disease and the beneficial effects of calorie restriction. Heart Failure Reviews. 17: 707-19. PMID 22095297 DOI: 10.1007/s10741-011-9293-8  1
2012 Kok BP, Kienesberger PC, Dyck JR, Brindley DN. Relationship of glucose and oleate metabolism to cardiac function in lipin-1 deficient (fld) mice. Journal of Lipid Research. 53: 105-18. PMID 22058427 DOI: 10.1194/jlr.M019430  1
2011 Durgan DJ, Pat BM, Laczy B, Bradley JA, Tsai JY, Grenett MH, Ratcliffe WF, Brewer RA, Nagendran J, Villegas-Montoya C, Zou C, Zou L, Johnson RL, Dyck JR, Bray MS, et al. O-GlcNAcylation, novel post-translational modification linking myocardial metabolism and cardiomyocyte circadian clock. The Journal of Biological Chemistry. 286: 44606-19. PMID 22069332 DOI: 10.1074/jbc.M111.278903  1
2011 Dolinsky VW, Rueda-Clausen CF, Morton JS, Davidge ST, Dyck JR. Continued postnatal administration of resveratrol prevents diet-induced metabolic syndrome in rat offspring born growth restricted. Diabetes. 60: 2274-84. PMID 21810598 DOI: 10.2337/db11-0374  1
2011 Dolinsky VW, Dyck JR. Calorie restriction and resveratrol in cardiovascular health and disease. Biochimica Et Biophysica Acta. 1812: 1477-89. PMID 21749920 DOI: 10.1016/j.bbadis.2011.06.010  1
2011 Luong C, Rey-Perra J, Vadivel A, Gilmour G, Sauve Y, Koonen D, Walker D, Todd KG, Gressens P, Kassiri Z, Nadeem K, Morgan B, Eaton F, Dyck JR, Archer SL, et al. Antenatal sildenafil treatment attenuates pulmonary hypertension in experimental congenital diaphragmatic hernia. Circulation. 123: 2120-31. PMID 21537000 DOI: 10.1161/CIRCULATIONAHA.108.845909  1
2011 Lauzier B, Merlen C, Vaillant F, McDuff J, Bouchard B, Beguin PC, Dolinsky VW, Foisy S, Villeneuve LR, Labarthe F, Dyck JR, Allen BG, Charron G, Des Rosiers C. Post-translational modifications, a key process in CD36 function: lessons from the spontaneously hypertensive rat heart. Journal of Molecular and Cellular Cardiology. 51: 99-108. PMID 21510957 DOI: 10.1016/j.yjmcc.2011.04.001  1
2011 Durgan DJ, Tsai JY, Grenett MH, Pat BM, Ratcliffe WF, Villegas-Montoya C, Garvey ME, Nagendran J, Dyck JR, Bray MS, Gamble KL, Gimble JM, Young ME. Evidence suggesting that the cardiomyocyte circadian clock modulates responsiveness of the heart to hypertrophic stimuli in mice. Chronobiology International. 28: 187-203. PMID 21452915 DOI: 10.3109/07420528.2010.550406  1
2011 Sung MM, Koonen DP, Soltys CL, Jacobs RL, Febbraio M, Dyck JR. Increased CD36 expression in middle-aged mice contributes to obesity-related cardiac hypertrophy in the absence of cardiac dysfunction. Journal of Molecular Medicine (Berlin, Germany). 89: 459-69. PMID 21387178 DOI: 10.1007/s00109-010-0720-4  1
2011 Cole LK, Dolinsky VW, Dyck JR, Vance DE. Impaired phosphatidylcholine biosynthesis reduces atherosclerosis and prevents lipotoxic cardiac dysfunction in ApoE-/- Mice. Circulation Research. 108: 686-94. PMID 21273556 DOI: 10.1161/CIRCRESAHA.110.238691  1
2011 Rueda-Clausen CF, Dolinsky VW, Morton JS, Proctor SD, Dyck JR, Davidge ST. Hypoxia-induced intrauterine growth restriction increases the susceptibility of rats to high-fat diet-induced metabolic syndrome. Diabetes. 60: 507-16. PMID 21270262 DOI: 10.2337/db10-1239  1
2011 Sung MM, Soltys CL, Masson G, Boisvenue JJ, Dyck JR. Improved cardiac metabolism and activation of the RISK pathway contributes to improved post-ischemic recovery in calorie restricted mice. Journal of Molecular Medicine (Berlin, Germany). 89: 291-302. PMID 21140129 DOI: 10.1007/s00109-010-0703-5  1
2011 Alphonse RS, Vadivel A, Coltan L, Eaton F, Barr AJ, Dyck JR, Thébaud B. Activation of Akt protects alveoli from neonatal oxygen-induced lung injury. American Journal of Respiratory Cell and Molecular Biology. 44: 146-54. PMID 20348209 DOI: 10.1165/rcmb.2009-0182OC  1
2011 Dyck JRB, Sung MMY. Energy metabolism in the aging heart Heart and Metabolism. 3-7.  1
2010 Sutendra G, Bonnet S, Rochefort G, Haromy A, Folmes KD, Lopaschuk GD, Dyck JR, Michelakis ED. Fatty acid oxidation and malonyl-CoA decarboxylase in the vascular remodeling of pulmonary hypertension. Science Translational Medicine. 2: 44ra58. PMID 20702857 DOI: 10.1126/scitranslmed.3001327  1
2010 Dolinsky VW, Morton JS, Oka T, Robillard-Frayne I, Bagdan M, Lopaschuk GD, Des Rosiers C, Walsh K, Davidge ST, Dyck JR. Calorie restriction prevents hypertension and cardiac hypertrophy in the spontaneously hypertensive rat. Hypertension. 56: 412-21. PMID 20696994 DOI: 10.1161/HYPERTENSIONAHA.110.154732  1
2010 Archer SL, Marsboom G, Kim GH, Zhang HJ, Toth PT, Svensson EC, Dyck JR, Gomberg-Maitland M, Thébaud B, Husain AN, Cipriani N, Rehman J. Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target. Circulation. 121: 2661-71. PMID 20529999 DOI: 10.1161/CIRCULATIONAHA.109.916098  1
2010 Jacobs RL, Zhao Y, Koonen DP, Sletten T, Su B, Lingrell S, Cao G, Peake DA, Kuo MS, Proctor SD, Kennedy BP, Dyck JR, Vance DE. Impaired de novo choline synthesis explains why phosphatidylethanolamine N-methyltransferase-deficient mice are protected from diet-induced obesity. The Journal of Biological Chemistry. 285: 22403-13. PMID 20452975 DOI: 10.1074/jbc.M110.108514  1
2010 Hamming KS, Soliman D, Webster NJ, Searle GJ, Matemisz LC, Liknes DA, Dai XQ, Pulinilkunnil T, Riedel MJ, Dyck JR, Macdonald PE, Light PE. Inhibition of beta-cell sodium-calcium exchange enhances glucose-dependent elevations in cytoplasmic calcium and insulin secretion. Diabetes. 59: 1686-93. PMID 20413506 DOI: 10.2337/db09-0630  1
2010 Kraus A, Groenendyk J, Bedard K, Baldwin TA, Krause KH, Dubois-Dauphin M, Dyck J, Rosenbaum EE, Korngut L, Colley NJ, Gosgnach S, Zochodne D, Todd K, Agellon LB, Michalak M. Calnexin deficiency leads to dysmyelination. The Journal of Biological Chemistry. 285: 18928-38. PMID 20400506 DOI: 10.1074/jbc.M110.107201  1
2010 Koonen DP, Sung MM, Kao CK, Dolinsky VW, Koves TR, Ilkayeva O, Jacobs RL, Vance DE, Light PE, Muoio DM, Febbraio M, Dyck JR. Alterations in skeletal muscle fatty acid handling predisposes middle-aged mice to diet-induced insulin resistance. Diabetes. 59: 1366-75. PMID 20299464 DOI: 10.2337/db09-1142  1
2010 Wei E, Ben Ali Y, Lyon J, Wang H, Nelson R, Dolinsky VW, Dyck JR, Mitchell G, Korbutt GS, Lehner R. Loss of TGH/Ces3 in mice decreases blood lipids, improves glucose tolerance, and increases energy expenditure. Cell Metabolism. 11: 183-93. PMID 20197051 DOI: 10.1016/j.cmet.2010.02.005  1
2010 Brindley DN, Kok BP, Kienesberger PC, Lehner R, Dyck JR. Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization. American Journal of Physiology. Endocrinology and Metabolism. 298: E897-908. PMID 20103741 DOI: 10.1152/ajpendo.00509.2009  1
2010 Durgan DJ, Pulinilkunnil T, Villegas-Montoya C, Garvey ME, Frangogiannis NG, Michael LH, Chow CW, Dyck JR, Young ME. Short communication: ischemia/reperfusion tolerance is time-of-day-dependent: mediation by the cardiomyocyte circadian clock. Circulation Research. 106: 546-50. PMID 20007913 DOI: 10.1161/CIRCRESAHA.109.209346  1
2010 Tsai JY, Kienesberger PC, Pulinilkunnil T, Sailors MH, Durgan DJ, Villegas-Montoya C, Jahoor A, Gonzalez R, Garvey ME, Boland B, Blasier Z, McElfresh TA, Nannegari V, Chow CW, Heird WC, ... ... Dyck JR, et al. Direct regulation of myocardial triglyceride metabolism by the cardiomyocyte circadian clock. The Journal of Biological Chemistry. 285: 2918-29. PMID 19940111 DOI: 10.1074/jbc.M109.077800  1
2009 Folmes KD, Chan AY, Koonen DP, Pulinilkunnil TC, Baczkó I, Hunter BE, Thorn S, Allard MF, Roberts R, Gollob MH, Light PE, Dyck JR. Distinct early signaling events resulting from the expression of the PRKAG2 R302Q mutant of AMPK contribute to increased myocardial glycogen. Circulation. Cardiovascular Genetics. 2: 457-66. PMID 20031621 DOI: 10.1161/CIRCGENETICS.108.834564  1
2009 Ikeda Y, Sato K, Pimentel DR, Sam F, Shaw RJ, Dyck JR, Walsh K. Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction. The Journal of Biological Chemistry. 284: 35839-49. PMID 19828446 DOI: 10.1074/jbc.M109.057273  1
2009 Bonnet S, Paulin R, Sutendra G, Dromparis P, Roy M, Watson KO, Nagendran J, Haromy A, Dyck JR, Michelakis ED. Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-{beta}/NFAT axis. Circulation. 120: 1231-40. PMID 19752325 DOI: 10.1161/CIRCULATIONAHA.109.848911  1
2009 Ussher JR, Koves TR, Jaswal JS, Zhang L, Ilkayeva O, Dyck JR, Muoio DM, Lopaschuk GD. Insulin-stimulated cardiac glucose oxidation is increased in high-fat diet-induced obese mice lacking malonyl CoA decarboxylase. Diabetes. 58: 1766-75. PMID 19478144 DOI: 10.2337/db09-0011  1
2009 Dyck J, Gosgnach S. Whole cell recordings from visualized neurons in the inner laminae of the functionally intact spinal cord. Journal of Neurophysiology. 102: 590-7. PMID 19386756 DOI: 10.1152/jn.00212.2009  1
2009 Saeedi R, Saran VV, Wu SS, Kume ES, Paulson K, Chan AP, Parsons HL, Wambolt RB, Dyck JR, Brownsey RW, Allard MF. AMP-activated protein kinase influences metabolic remodeling in H9c2 cells hypertrophied by arginine vasopressin. American Journal of Physiology. Heart and Circulatory Physiology. 296: H1822-32. PMID 19376807 DOI: 10.1152/ajpheart.00396.2008  1
2009 Dolinsky VW, Chan AY, Robillard Frayne I, Light PE, Des Rosiers C, Dyck JR. Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1. Circulation. 119: 1643-52. PMID 19289642 DOI: 10.1161/CIRCULATIONAHA.108.787440  1
2009 Ussher JR, Koves TR, Jaswal JS, Zhang L, Ilkayeva O, Dyck JRB, Muoio DM, Lopaschuk GD. Insulin-stimulated cardiac glucose oxidation is increased in high-fat diet-induced obese mice lacking malonyl CoA decarboxylase (Diabetes (2009) 58, (1766-1775)) Diabetes. 58: 2425.  1
2008 Zhang Y, Narayan S, Geiman E, Lanuza GM, Velasquez T, Shanks B, Akay T, Dyck J, Pearson K, Gosgnach S, Fan CM, Goulding M. V3 spinal neurons establish a robust and balanced locomotor rhythm during walking. Neuron. 60: 84-96. PMID 18940590 DOI: 10.1016/j.neuron.2008.09.027  1
2008 Nagendran J, Gurtu V, Fu DZ, Dyck JR, Haromy A, Ross DB, Rebeyka IM, Michelakis ED. A dynamic and chamber-specific mitochondrial remodeling in right ventricular hypertrophy can be therapeutically targeted. The Journal of Thoracic and Cardiovascular Surgery. 136: 168-78, 178.e1-3. PMID 18603070 DOI: 10.1016/j.jtcvs.2008.01.040  1
2008 Chan AY, Dolinsky VW, Soltys CL, Viollet B, Baksh S, Light PE, Dyck JR. Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt. The Journal of Biological Chemistry. 283: 24194-201. PMID 18562309 DOI: 10.1074/jbc.M802869200  1
2008 Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, Bain J, Stevens R, Dyck JR, Newgard CB, Lopaschuk GD, Muoio DM. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metabolism. 7: 45-56. PMID 18177724 DOI: 10.1016/j.cmet.2007.10.013  1
2008 Bray MS, Shaw CA, Moore MW, Garcia RA, Zanquetta MM, Durgan DJ, Jeong WJ, Tsai JY, Bugger H, Zhang D, Rohrwasser A, Rennison JH, Dyck JR, Litwin SE, Hardin PE, et al. Disruption of the circadian clock within the cardiomyocyte influences myocardial contractile function, metabolism, and gene expression. American Journal of Physiology. Heart and Circulatory Physiology. 294: H1036-47. PMID 18156197 DOI: 10.1152/ajpheart.01291.2007  1
2007 Koonen DP, Jacobs RL, Febbraio M, Young ME, Soltys CL, Ong H, Vance DE, Dyck JR. Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes. 56: 2863-71. PMID 17728375 DOI: 10.2337/db07-0907  1
2007 Durgan DJ, Moore MW, Ha NP, Egbejimi O, Fields A, Mbawuike U, Egbejimi A, Shaw CA, Bray MS, Nannegari V, Hickson-Bick DL, Heird WC, Dyck JR, Chandler MP, Young ME. Circadian rhythms in myocardial metabolism and contractile function: influence of workload and oleate. American Journal of Physiology. Heart and Circulatory Physiology. 293: H2385-93. PMID 17616739 DOI: 10.1152/ajpheart.01361.2006  1
2007 Nagendran J, Archer SL, Soliman D, Gurtu V, Moudgil R, Haromy A, St Aubin C, Webster L, Rebeyka IM, Ross DB, Light PE, Dyck JR, Michelakis ED. Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility. Circulation. 116: 238-48. PMID 17606845 DOI: 10.1161/CIRCULATIONAHA.106.655266  1
2007 Khairallah M, Khairallah R, Young ME, Dyck JR, Petrof BJ, Des Rosiers C. Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy. Journal of Molecular and Cellular Cardiology. 43: 119-29. PMID 17583724 DOI: 10.1016/j.yjmcc.2007.05.015  1
2007 Jacobs RL, Lingrell S, Dyck JR, Vance DE. Inhibition of hepatic phosphatidylcholine synthesis by 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside is independent of AMP-activated protein kinase activation. The Journal of Biological Chemistry. 282: 4516-23. PMID 17179149 DOI: 10.1074/jbc.M605702200  1
Show low-probability matches.